Biosurgery SURGICEL®

SURGICEL® Family of Absorbable Hemostats

With proprietary Oxidized Regenerated Cellulose (ORC) technology, the SURGICEL® Family of Absorbable Hemostats delivers predictable and consistent results. These flexible and malleable plant-based products are fully absorbable within 7-14 days and can be cut to size.

• SURGICEL Original Absorbable Hemostat
• SURGICEL SNoW Absorbable Hemostat
• SURGICEL FIBRILLAR Absorbable Hemostat
• SURGICEL NU-KNIT Absorbable Hemostat

Wound Closure – STRATAFIX

STRATAFIX Knotless Tissue Control Devices

The STRATAFIX Knotless Tissue Control Device portfolio now contains three devices with Plus Antibacterial Technology

• STRATAFIX Symmetric PDS Plus Knotless Tissue Control Device
• STRATAFIX Spiral MONOCRYL Plus Knotless Tissue Control Device
• STRATAFIX Spiral PDS Plus Knotless Tissue Control Device

– Offers greater strength & security of interrupted closure, without knots

– More consistent tension control and approximation during closure

– More efficient than continuous or interrupted suturing

Wound Closure – PLUS Suture

The Plus Antibacterial Suture portfolio includes

• MONOCRYL® Plus Antibacterial (poliglecaprone 25) Suture
• Coated VICRYL® Plus Antibacterial (polyglactin 910) Suture
• PDS® Plus Antibacterial (polydioxanone) Suture

The antibacterial component of all Plus Sutures — IRGACARE® MP —represents the purest form of triclosan, shown to inhibit colonization on the device in vitro for seven days or more, while providing a favorable safety profile spanning over 40 years.

The Who, and ACS & SIS suggests the use of triclosan-coated sutures. The WHO suggests use these types of sutures in their Global Guidelines for the Prevention of Surgical Site Infections, and the ACS and SIS recommend use in their updated Surgical Site Infection Guidelines. These updated guidelines support our decade-long commitment to helping surgeons and their institutions address the overwhelming burden of healthcare associated infections.